FDA Approved: FARESTON — Supplemental Application (Kyowa Kirin, Inc.)

View source ↗

Summary

FDA supplemental approval for Fareston (toremifene citrate) to update the labeling for this breast cancer therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FARESTON (toremifene citrate)

Snippet

SUPPL AP for FARESTON (TOREMIFENE CITRATE)